NVI logo
National Vaccine Institute Republic of Ghana

NVI – WHO Clinical Trials Ecosystem Assessment Workshop

NVI – WHO Clinical Trials Ecosystem Assessment Workshop
The National Vaccine Institute (NVI), in collaboration with the World Health Organization (WHO) and with the support of the European Union in Ghana successfully concluded the two-day Clinical Trials Ecosystem Assessment Workshop held at the Volta Serene Hotel, Ho. Building on the strong momentum of the opening day, the second day focused on practical application of the WHO Benchmarking Tool, with participating institutions forming self-assessment teams, assigning institutional responsibilities, conducting simulated assessments, and developing strategies for implementing the pilot within their respective organizations. Participants also agreed on mechanisms for progress monitoring, evidence validation, data analysis, and the submission of institutional self-assessment reports, marking an important milestone towards strengthening Ghana's clinical trials ecosystem.
The successful completion of the workshop reflects Ghana's growing commitment to building world-class institutional capacity for clinical research and creating an enabling environment for ethical, high-quality, and globally competitive clinical trials. The workshop fostered meaningful collaboration among research institutions, academia, regulatory agencies, healthcare professionals, and development partners, while equipping participants with practical knowledge and tools to drive continuous institutional improvement.
The National Vaccine Institute expresses its profound appreciation to the World Health Organization Headquarters, World Health Organization Ghana Country Office, WHO AFRO, the European Union, all facilitators, speakers, moderators, participating institutions, and every stakeholder whose expertise, dedication, and active participation contributed to the outstanding success of the workshop.
Together, we have taken another significant step towards advancing vaccine research, strengthening health systems, and positioning Ghana as a leading destination for high-quality clinical trials in Africa.
← Back to Newsroom Published August 17, 2026